- Filings
- Filing Tables
-
Filing Analysis
- News
- Transcripts
- Patents
XLRN
Acceleron Pharma
|
26 | |
Merck Sharp & Dohme
|
7 | |
Avoro Capital Advisors
|
4 | |
The Nasdaq Stock Market LLC
|
1 | |
Holocene Advisors
|
1 | |
Darwin Global Management
|
1 |
SC 14D9/A | 7 | |
SC 14D9 | 4 | |
SC TO-T/A | 4 | |
S-8 | 2 | |
SC TO-C | 2 | |
SC14D9C | 2 | |
15-12B | 1 | |
25-NSE | 1 | |
424B2 | 1 | |
424B5 | 1 |